Single Source Procurement: End of AIDS - Syringe Exchange Program Enhancement

Pursuant to New York State Finance Law § 163.10(b), The New York State Department of Health is presenting the following summary of relevant circumstances, and material and substantial reasons why a competitive procurement was not feasible.

HIV and AIDS in New York State cannot be addressed without focusing on injection drug users (IDUs) and syringe exchange programs. The Syringe Exchange Programs (SEP) initiative was established in 1992 to address the HIV epidemic in injection drug users. Syringe exchange is the one intervention that can be described as the gold standard of HIV prevention for injecting drug users. The data shows that syringe exchange is one of the most successful HIV prevention initiatives of the AIDS Institute, based on the numbers of lives and health care dollars saved. In 1992, 52 percent of newly diagnosed AIDS cases were among IDUs. In 2012, IDU risk accounted for only 3 percent of new HIV diagnoses.

The SEP was initially approved through a procurement for the period of 7/1/2013–6/30/2018. An amendment to that procurement was subsequently approved, which contained program expansions for reaching young intravenous drug users - component 2 for a period of 7/1/2014-6/30/2016. The NYSDOH AIDS Institute is requesting additional amendments to several Harm Reduction/Syringe Exchange Program contracts for program enhancements to implement the goals for the “Ending the Epidemic” initiative. These vendors are the most appropriate channels for these one-time funds.

Procurement / Program Name	End of AIDS - Syringe Exchange Program Enhancement
Contractor Name(s)	Multiple – Please See Attached.
Contract Period	7/1/2016 – 6/30/2018
Contract Number(s)	Multiple – Please See Attached.